ShoulderUp Technology Acquisition Corp. (SUAC)
USD 10.8
(0.0%)
USD 10.8
(0.0%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -1.97 Million | -1.04 Million | -1017.08 |
| Net Income | 332.33 Thousand | 2.42 Million | -385.15 |
| Depreciation & Amortization | - | - | - |
| Deferred income taxes | - | - | - |
| Stock-based compensation | - | - | - |
| Change in working capital | 405.19 Thousand | 932.06 Thousand | -368.62 Thousand |
| Other non-cash items | -2.71 Million | -4.4 Million | 367.99 Thousand |
| Investing Cash Flow | 294.46 Million | 668.86 Thousand | -524.57 Thousand |
| Investments in PPE | - | - | - |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | 294.46 Million | 668.86 Thousand | -524.57 Thousand |
| Financing Cash Flow | -292.5 Million | - | 526.94 Thousand |
| Debt repayment | - | - | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | -292.5 Million | - | - |
| Common Stock Issuance | - | - | 25 Thousand |
| Other Financing Activities | -292.5 Million | - | 501.94 Thousand |
| Accounts receivables | - | - | - |
| Accounts payables | 246.01 Thousand | 247.28 Thousand | 23.92 Thousand |
| Inventory | - | - | - |
| Other working capital | 159.18 Thousand | 684.77 Thousand | -392.55 Thousand |
| Cash at beginning of period | 409.72 Thousand | 790.77 Thousand | 0.08 |
| Cash at end of period | 403.45 Thousand | 409.72 Thousand | 790.77 Thousand |
| Capital Expenditure | - | - | - |
| Effect of forex changes on cash | - | - | 789.41 Thousand |
| Net cash flow / Change in cash | -6269.00 | -381.04 Thousand | 790.76 Thousand |
| Free Cash Flow | -1.97 Million | -1.04 Million | -1017.08 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -222.79 Thousand | -439.98 Thousand | 332.33 Thousand | -2.94 Million | 73.09 Thousand | 855.37 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -91.21 Thousand | 381.66 Thousand | 405.19 Thousand | 233.89 Thousand | -355.38 Thousand | -172.05 Thousand |
| Other non-cash items | -155.83 Thousand | - | - | 2.94 Million | -476.05 Thousand | -1.48 Million |
| Investing Cash Flow | 12.28 Million | - | 294.46 Million | 23.35 Million | 40 Thousand | 270.97 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 12.28 Million | - | 294.46 Million | 23.35 Million | 40 Thousand | 270.97 Million |
| Financing Cash Flow | - | - | -292.5 Million | -22.9 Million | -269.59 Thousand | -269.59 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -292.5 Million | -22.9 Million | -269.59 Thousand | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -292.5 Million | -292.23 Million | 269.59 Thousand | -269.59 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 133.97 Thousand | 254.97 Thousand | 246.01 Thousand | 58.31 Thousand | 52.91 Thousand | 76.7 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -225.18 Thousand | - | - | 715.14 Thousand | -408.3 Thousand | -248.76 Thousand |
| Cash at beginning of period | 335.3 Thousand | 403.45 Thousand | 409.72 Thousand | 130.3 Thousand | 848.63 Thousand | 273.96 Thousand |
| Cash at end of period | 290.46 Thousand | 335.3 Thousand | 403.45 Thousand | 403.45 Thousand | 130.3 Thousand | 848.63 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | 269.05 Million | 269.59 Thousand | -269.32 Million |
| Net cash flow / Change in cash | -44.83 Thousand | -68.15 Thousand | -6269.00 | 273.15 Thousand | -718.33 Thousand | 574.67 Thousand |
| Free Cash Flow | -469.83 Thousand | -68.15 Thousand | -1.97 Million | -176.84 Thousand | -758.33 Thousand | -801.52 Thousand |
PARNAXLAB
EQC-PD
GELGF
600170
OLVI
002403